Chen Danyang, Zhao Zhixian, Zhang Shenglun, Chen Shiling, Wu Xuan, Shi Jian, Liu Na, Pan Chao, Tang Yingxin, Meng Cai, Zhao Xingwei, Tao Bo, Liu Wenjie, Chen Diansheng, Ding Han, Zhang Ping, Tang Zhouping
Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
School of Mechanical Science and Engineering, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Transl Stroke Res. 2025 Jun;16(3):975-989. doi: 10.1007/s12975-024-01244-x. Epub 2024 Apr 1.
Intracerebral hemorrhage (ICH) is the most serious form of stroke and has limited available therapeutic options. As knowledge on ICH rapidly develops, cutting-edge techniques in the fields of surgical robots, regenerative medicine, and neurorehabilitation may revolutionize ICH treatment. However, these new advances still must be translated into clinical practice. In this review, we examined several emerging therapeutic strategies and their major challenges in managing ICH, with a particular focus on innovative therapies involving robot-assisted minimally invasive surgery, stem cell transplantation, in situ neuronal reprogramming, and brain-computer interfaces. Despite the limited expansion of the drug armamentarium for ICH over the past few decades, the judicious selection of more efficacious therapeutic modalities and the exploration of multimodal combination therapies represent opportunities to improve patient prognoses after ICH.
脑出血(ICH)是最严重的中风形式,可用的治疗选择有限。随着对脑出血的认识迅速发展,手术机器人、再生医学和神经康复领域的前沿技术可能会彻底改变脑出血的治疗方式。然而,这些新进展仍必须转化为临床实践。在本综述中,我们研究了几种新兴的治疗策略及其在管理脑出血方面的主要挑战,特别关注涉及机器人辅助微创手术、干细胞移植、原位神经元重编程和脑机接口的创新疗法。尽管在过去几十年中用于脑出血的药物储备扩充有限,但明智地选择更有效的治疗方式以及探索多模式联合疗法为改善脑出血患者的预后提供了机会。